menu search

MEDP / Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Medpace (MEDP)

Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Medpace (MEDP)
The heavy selling pressure might have exhausted for Medpace (MEDP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. Read More
Posted: Feb 16 2022, 11:35
Author Name: Zacks Investment Research
Views: 111885

MEDP News  

Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
November 1, 2023

Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?

Here is how Medpace (MEDP) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year. more_horizontal

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

By Zacks Investment Research
October 26, 2023

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

Medpace (MEDP) could produce exceptional returns because of its solid growth attributes. more_horizontal

Medpace (MEDP) Upgraded to Buy: Here's What You Should Know

By Zacks Investment Research
October 26, 2023

Medpace (MEDP) Upgraded to Buy: Here's What You Should Know

Medpace (MEDP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). more_horizontal

Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates

By Zacks Investment Research
October 23, 2023

Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates

Medpace (MEDP) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings more_horizontal

Are Medical Stocks Lagging Medpace (MEDP) This Year?

By Zacks Investment Research
October 13, 2023

Are Medical Stocks Lagging Medpace (MEDP) This Year?

Here is how Medpace (MEDP) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year. more_horizontal

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think

By Zacks Investment Research
September 25, 2023

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials. more_horizontal

Medpace: A Great Anchor For A Long-Term Portfolio

By Seeking Alpha
September 9, 2023

Medpace: A Great Anchor For A Long-Term Portfolio

Medpace is a Contract Research Organization (CRO) that provides outsourced clinical development services to the biotech, pharma, and medical device in more_horizontal

Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

By Zacks Investment Research
September 8, 2023

Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials. more_horizontal


Search within

Pages Search Results: